Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at
opm.gov.
Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Influence of fluoxetine on the disposition kinetics of dolutegravir among people living with HIV with major depression in Nigeria
Principal Institution
College of Medicine, University of Ibadan
Principal Investigator(s) (PI)
Adedeji, Waheed Adeola
Project Contact Information
Email:
wad_deji@yahoo.com
Year(s) Awarded
2022–2027
Country
Nigeria
NIH Partners
NIMH
Project Description
The overall goal of this project is to provide advanced training to equip Dr. Adedeji Waheed A (a physician/scientist) with skills and competencies in clinical trials, population pharmacokinetics, pharmacokinetics/pharmacodynamics modeling, and pharmacogenomics. These skills will equip Dr. Adedeji to establish a research career in HIV clinical pharmacology and pharmacogenomics. The burden of HIV/AIDS is of global health concern, and Nigeria has the third largest burden of the disease in the world but lacks research capacity in HIV clinical pharmacology and pharmacogenomics.
Related World Regions / Countries
Related Global Health Research Topics